Patent application number | Description | Published |
20090221559 | BENZODIAZEPINES AS HCV INHIBITORS - The present invention relates to the use of benzodiazepines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to benzodiazepine compounds per se and their use as medicines. The present invention also concerns processes for the preparation of such compounds, pharmaceutical compositions comprising them, and combinations of said compounds with other anti-HCV agents. | 09-03-2009 |
20090247523 | CARBOXAMIDE 4-[(4-PYRIDYL)AMINO]PYRIMIDINES USEFUL AS HCV INHIBITORS - The present invention relates to the use of carboxamide 4-[(4-pyridyl)amino]-pyrimidines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. | 10-01-2009 |
20100041728 | HCV INHIBITING MACROCYCLIC PHENYLCARBAMATES - Compounds of the formula 1: | 02-18-2010 |
20100113440 | PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS - Compounds of the Formula (I) including a stereoisomer thereof, or an N-oxide, a pharmaceutically acceptable addition salt, or a pharmaceutically acceptable addition solvate thereof; useful as HCV inhibitors; processes for preparing these compounds as well as pharmaceutical compositions comprising these compounds as active ingredient. | 05-06-2010 |
20110230436 | Uracyl Cyclopropyl Nucleotides - Compounds of the formula I: | 09-22-2011 |
20120034678 | Diaryl Ethers - Compounds of the formula I: | 02-09-2012 |
20120135953 | Bis-Benzimidazole Derivatives As Hepatitis C Virus Inhibitors - Inhibitors of HCV replication of formula I | 05-31-2012 |
20120136027 | Phenyl Ethynyl Derivatives As Hepatitis C Virus Inhibitors - Inhibitors of HCV replication of formula I | 05-31-2012 |
20120172368 | Bis-Benzimidazole Derivatives - Inhibitors of HCV replication of formula I | 07-05-2012 |
20120219594 | Benzimidazole-imidazole Derivatives - Inhibitors of HCV replication of formula I | 08-30-2012 |
20120220520 | BIOAVAILABLE COMBINATIONS FOR HCV TREATMENT - The present invention relates to the combination comprising an HCV NS3/4a protease inhibitor and a compound of formula (II). The combination is useful to improve the bioavailability of the HCV NS3/4a protease inhibitor. As such, the combination is useful for treating conditions associated with the Hepatitis C virus in patients. Pharmaceutical compositions and kits comprising this combination, and processes for preparing the combination and the pharmaceutical formulations are also provided. | 08-30-2012 |
20130028865 | Combination of a Macrocyclic Inhibitor of HCV, A Non-Nucleoside and a Nucleoside - The present invention relates to a combination of a macrocyclic HCV protease inhibitor, a macrocyclic non-nucleoside HCV polymerase inhibitor and a nucleoside HCV polymerase inhibitor. | 01-31-2013 |
20130109694 | COMPOUNDS WITH ANTIBACTERIAL ACTIVITY AGAINST CLOSTRIDIUM | 05-02-2013 |
20130123244 | Hetero-Bicyclic Derivatives as HCV Inhibitors - Inhibitors of HCV replication of formula I | 05-16-2013 |
20130217648 | Uracyl Spirooxetane Nucleosides - Compounds of the formula I: | 08-22-2013 |
20130225520 | Uracyl Spirooxetane Nucleoside Phosphoramidates - This invention relates to a stereochemically pure uracyl spirooxetane nucleoside phosphoramidate which inhibits the hepatitis C virus (HCV). | 08-29-2013 |
20130244968 | Uracyl Spirooxetane Nucleoside Phosphoramidates - This invention relates to a stereochemically pure uracyl spirooxetane nucleoside phosphoramidate useful in the treatment of patients infected with the hepatitis C virus (HCV). | 09-19-2013 |
20130261151 | AZABENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS - A compound satisfying formula I, a prodrug, N-oxide, addition salt, quaternary amine, metal complex, or a stereochemically isomeric form thereof; | 10-03-2013 |
20130267508 | BENZIMIDAZOLE RESPIRATORY SYNCYTIAL VIRUS INHIBITORS - Benzimidazoles having inhibitory activity on RSV replication and having the formula | 10-10-2013 |
20130267555 | INDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS - Indoles having inhibitory activity on RSV replication and having the formula I | 10-10-2013 |
20130267556 | AZAINDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS - Azaindoles having inhibitory activity on RSV replication and having the formula I | 10-10-2013 |
20130324527 | IMIDAZOPYRIDINES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS - A compound satisfying formula I, a prodrug, N-oxide, addition salt, quaternary amine, metal complex, or a stereochemically isomeric form thereof: | 12-05-2013 |
20140073642 | QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES - This invention relates to quinazoline derivatives, processes for their preparation, pharmaceutical compositions, and their use in therapy of disorders in which the modulation of toll-like-receptors is involved. | 03-13-2014 |
20140107172 | Benzimidazole-imidazole derivatives - Inhibitors of HCV replication of formula I | 04-17-2014 |
20140350031 | Piperidino-pyrimidine derivatives for the treatment of viral infections - This invention relates to piperidino-pyhmidine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections. | 11-27-2014 |
20140357626 | Hetero-Bicyclic Derivatives As HCV Inhibitors - Inhibitors of HCV replication of formula I, including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R′ have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in HCV therapy. | 12-04-2014 |
20140378485 | QUINAZOLINONE DERIVATIVES AS HCV INHIBITORS - Inhibitors of HCV replication of formula (I) including stereochemically isomeric forms, salts, and solvates thereof, wherein R and R′ have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in HCV therapy. | 12-25-2014 |
20150073012 | AZABENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS - A compound satisfying formula I, a prodrug, N-oxide, addition salt, quaternary amine, metal complex, or a stereochemically isomeric form thereof; | 03-12-2015 |
20150073013 | INDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS - Indoles having inhibitory activity on RSV replication and having the formula I | 03-12-2015 |